Syngenta AG H1 2020 Financial Results July 22, 2020 - - PowerPoint PPT Presentation

▶
syngenta ag h1 2020 financial results
SMART_READER_LITE
LIVE PREVIEW

Syngenta AG H1 2020 Financial Results July 22, 2020 - - PowerPoint PPT Presentation

Nov 27, 2022 231 likes •373 views

Syngenta AG H1 2020 Financial Results July 22, 2020 Classification: PUBLIC Cautionary statement regarding forward-looking statements Some of the statements contained in this document are forward-looking statements. These statements are based

slide-1
SLIDE 1

July 22, 2020

Syngenta AG H1 2020 Financial Results

Classification: PUBLIC

slide-2
SLIDE 2

Some of the statements contained in this document are forward-looking statements. These statements are based on current expectations, assumptions, estimates and projections, and involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to be materially different from any forward-looking statements. These statements are generally identified by words or phrases such as "believe", "anticipate", "expect", "intend", "plan", "will", "may", "should", "estimate", "predict", "potential", "continue" or the negative of such terms or other similar expressions. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results and the timing of events may differ materially from the results and/or timing discussed in the forward-looking statements, and you should not place undue reliance on these

  • statements. Syngenta disclaims any intent or obligation to update any forward-looking statements as a

result of developments occurring after the period covered by this document or otherwise.

2

Cautionary statement regarding forward-looking statements

Classification: PUBLIC

slide-3
SLIDE 3

*

Sales 6% higher, 11% at constant exchange rates (CER) excluding change of control royalties

Syngenta AG 2020 H1 Financial Performance

  • Sales $7.1 billion: 5% higher, 10% at CER*
  • Strong volume growth in Crop Protection; some $ sales

price erosion in Brazil from very volatile BRL

  • Seeds sales 9% higher adjusted for change of control

royalties

  • Strong US dollar reduced reported sales by 5%
  • EBITDA $1.7 billion, $1.5 billion excluding capitalized

development costs, 9% higher adjusted for change of control royalties; lower operating costs

  • Margin 0.5 percentage points higher adjusted for

change of control royalties

  • Excluding capitalized development, net income 11% lower

from 2019 one-off deferred tax gain, otherwise 18% higher

  • Free cash flow -$0.3 billion (2019: -$0.3 billion before US

litigation settlement)

3 Classification: PUBLIC

slide-4
SLIDE 4

H1 2020 sales vs. prior year

* Growth % vs PY adjusted for change of control

622 144

7,000 6,250 7,500 6,000 7,250 6,500 6,750

6,766

2020

  • 9

Flowers

  • 346

Currency

7,097

Crop Protection Adjusted 2019 CoC*

  • 80

2019

6,686

Seeds

ACT vs PY* CER vs PY*

+6% +8%

  • 9%

+12% +10%

  • 7%

+6% +11%

4 Classification: PUBLIC

slide-5
SLIDE 5

H1 2020 Syngenta CP sales: +6%; +12% at CER vs. PY*

Asia Pacific

  • Strong performance in Australia

due to improved weather conditions

  • Continued momentum from last

year in India

  • Significant unfavorable FX

impact

North America

  • Recovery in the US limited by

delayed planting as a result of cold weather and excessive rain in Q2

* Includes SPS and Sales to Seeds

+12% CER +8% ACT

Latin America

  • High pest pressure in Brazil.

Some sales anticipation due to volatile FX

  • Significant BRL volatility, some $

price erosion

  • Argentina higher volumes

despite difficult economic conditions +4% ACT +4% CER +10% ACT +32% CER

China

  • New fungicide strong demand
  • Seedcare channel growth
  • Continued momentum with

MAP/Sinofert and 3rd party products

+13% ACT +18% CER

Professional Solutions

  • Resilient performance across

regions despite COVID-19

  • Adverse FX impact
  • 2%

ACT flat CER

Europe & AME

  • Significant unfavorable

FX impact

  • Favorable business climate

in Russia

  • Soft demand in North West

Europe cereals due to dry weather

  • Strong performance in South

despite COVID-19 +5% CER

+2%

ACT

5 Classification: PUBLIC

slide-6
SLIDE 6

H1 2020 Syngenta Seeds sales: +7%; +9% at CER vs PY*

.

Asia Pacific

  • Continued growth momentum

across key geographies

  • Strong growth in Indonesia
  • Adverse currency impact

North America

  • Corn and Soy area recovery

(2019 flooding)

  • Estimated Soy share gain; strong

portfolio

  • Corn pricing and mix

improvement

+8% CER +5% ACT

Europe & AME

  • Strong seasonal growth limited

by Corn supply challenges

  • Sales impacted by strong Q4

2019 sell-in

  • Currency headwinds

flat

ACT flat CER

Latin America

  • Royalty income upside
  • LAS Sunflower area recovery

and expected share gain

  • Strong order position for

upcoming season

  • Unfavorable BRL currency

impact

+13%

ACT

+13%

CER +19% ACT +27% CER

China

  • Sanbei consolidation
  • Some supply impacts earlier in

the year

n/a

n/a

* Includes Flowers; Regional Sales exclude Vegetables & Flowers; Variances vs. PY adjusted for change of control

Global Veg

  • Strong growth across all regions;

some early phasing (COVID-19 mitigation)

  • Currency headwinds

+5% ACT +9% CER

6 Classification: PUBLIC

slide-7
SLIDE 7

2020 EBITDA progression vs. prior year

344

600 1,800 1,500 450 750 1,200 900 1,050 1,350 1,650

  • 86

Volume/Mix COGS/Inflation

  • 49
  • 97

Adjusted 2019

"One-off"-s

+10

2020

  • 80

2019

Price/FX Other net

1,461 1,381 1,503

Adjustments

+9%

FX

  • 143

Price: BR CP +57 Ukraine CP

  • 17

Seeds/Other +17 Oil +7 Salary Inflation

  • 46

COVID-19 Logistics -10 Disposals

  • 87

BDP

  • 10

1,675

Capitalized Development +172m

7 Classification: PUBLIC

slide-8
SLIDE 8

2020 Net Income vs. 2019

798 710 855 29 88 145

1,000 250 500 750 Capitalised Development (net of tax)

  • 28

Operating Income 2019 NFE/Other*

  • 177

Tax** Restructuring (net of tax) 2020 excl. Capitalised Development 2020

ACT vs PY

  • 11% [18%]

* Includes income from associates and non-controlling interests ** Excludes restructuring & impairment and capitalised development related tax impacts, includes one-off tax credit of $195m in 2019

[....] : growth adjusted for 2019 tax credit

8 Classification: PUBLIC

slide-9
SLIDE 9
  • 255
  • 258
  • 3

Acquisitions/ US Litigation Settlement EBITDA CAPEX

  • 1,064
  • 382
  • 33

Working Capital Financing, Tax, Other Restructuring & Disposals

  • 451

FCF b/f Acquisitions FCF

1,675

H1 2020 free cash flow vs. prior year

214 354 (145) (271) (78) 74 1107 1181 vs 2019*

* US Litigation Settlement in $1,110m 2019

9 Classification: PUBLIC

slide-10
SLIDE 10

Change in Net Debt

  • 0.4
  • 0.2
  • 0.1

H1 2019 Y/E 2019 H1 2020 Dividends Paid FCF H1 2020 FCF H2 2019 FX / Other

  • 0.3

Dividends Paid FX/Other

$bn

3.1 x EBITDA*

* Rolling 12 months EBITDA excluding capitalized development

Lease liabilities $0.5bn

1.7

  • 8.7
  • 7.6
  • 8.0

0.0

10 Classification: PUBLIC

slide-11
SLIDE 11

Working Capital ratios

11 Classification: PUBLIC

June 2018 June 2019 June 2020 41% 44% Trade Working Capital as % of sales (month end) 39% 32% 37%

  • Inventories

37% 42% 44%

  • Trade Receivables

38% 33% 37%

  • Trade Payables

36% 43% 42% Trade Working Capital as % of sales (average) 40%

slide-12
SLIDE 12

12

2020 Update

  • Retain first half cost savings
  • Maintaining investment in innovation and marketing;

sustainability agenda

  • Volume growth in Brazil; BRL volatility and weakness

contributing to some erosion in US dollar sales prices

  • Momentum building in China
  • COVID-19 resilience; some continued LATAM risk;

“second wave”

  • LATAM key to H2
  • Low to mid single digit sales growth
  • Cost savings to underpin margin
  • Continued free cash flow generation

Classification: PUBLIC

slide-13
SLIDE 13